MELOXICAM TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP26F6405 to DMS Pharmaceutical Group Inc on June 6, 2026. This award is a delivery order issued under the primary contract SPE2DX25D9900 for the procurement of Meloxicam tablets, identified by national stock number 6505015413243. The contract was managed by the Department of Defense and posted via the DIBBS system. While the total contract price is specified within the award documentation, the agreement focuses on the supply of pharmaceutical goods to support federal agency requirements.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
